Jane Street’s Lantern Pharma LTRN Stock Holding History

Jane Street’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24,872	Closed	-$150K	–	9850
2024 Q1	$219K	Buy	+24,872	New	+$133K	﹤0.01%	8057
2023 Q1	–	Sell	-15,134	Closed	-$91.4K	–	9539
2022 Q4	$91.4K	Buy	+15,134	New	+$75.8K	﹤0.01%	8144

Other funds holding LTRN

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jane Street's LTRN Position: Q2 2024 in Review

Jane Street sold out of Lantern Pharma (LTRN) in Q2 2024, closing a stake of 24,872 shares — an estimated $150K sold.

Jane Street first reported a position in LTRN in Q4 2022 and held it in 2 quarters. The position peaked at $219K in Q1 2024. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2024.

Jane Street reported no remaining Lantern Pharma position as of Q2 2024 after selling out during the quarter.
Jane Street sold 24,872 Lantern Pharma shares in Q2 2024, an estimated $150K.
Jane Street first reported a position in Lantern Pharma in Q4 2022 and held it in 2 quarters.
Jane Street's Lantern Pharma position peaked at $219K in Q1 2024.
39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.